Arch Therapeutics Reports Topline Results from Skin Sensitization Study of AC5
FRAMINGHAM, Mass., Sept. 05, 2018 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), developer of liquid, ...
Tag: Surgical Hemostatic Device
© Copyright 2022 publicwire.com